We are live on
!
Find out more
CDH
Charles D. Hyman Portfolio holdings
AUM
$1.79B
1-Year Est. Return
17.18%
This Fund
S&P 500
This Quarter
Est. Return
+0.84%
1 Year Est. Return
+17.18%
3 Year Est. Return
+36.79%
5 Year Est. Return
+95.96%
10 Year Est. Return
+199.04%
AUM
$486M
AUM Growth
–
Cap. Flow
+$492M
Cap. Flow
% of AUM
101.13%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
145
New
144
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$22.1M |
| 2 |
Johnson & Johnson
JNJ
|
+$21.6M |
| 3 |
PepsiCo
PEP
|
+$14.4M |
| 4 |
Emerson Electric
EMR
|
+$13.9M |
| 5 |
McDonald's
MCD
|
+$13.8M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.12% |
| 2 | Consumer Staples | 11.41% |
| 3 | Healthcare | 10.31% |
| 4 | Energy | 9.98% |
| 5 | Financials | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Alphabet (Google) Class C
GOOG
$3.9T
| $202K | 0.04% |
+9,194
| New | +$194K |
|
|
SONN
127
DELISTED
Sonnet BioTherapeutics
SONN
| – | – |
0
| – | – |
|
|
PBTH
128
DELISTED
PROLOR Biotech, Inc. Common Stock
PBTH
| $132K | 0.03% |
+21,000
| New | +$126K |
|
129
Regions Financial
RF
$26.3B
| $121K | 0.02% |
+12,730
| New | +$111K |
|
|
NWBO
130
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
| $68K | 0.01% |
+20,375
| New | +$73.9K |
|
|
GNMX
131
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $55K | 0.01% |
+14,500
| New | +$59.4K |
|
|
GNK
132
DELISTED
GENCO SHIPPING & TRADING LTD
GNK
| $26K | 0.01% |
+15,775
| New | +$27.6K |
|
|
HOTRW
133
DELISTED
CHANTICLEER HLDGS INC WTS EXP 6/11/2017 (DE)
HOTRW
| $20K | ﹤0.01% |
+44,444
| New | +$20K |
|
|
GSX
134
DELISTED
GASCO ENERGY INC
GSX
| $0 | ﹤0.01% |
+10,000
| New | +$374 |
|
|
CNB
135
DELISTED
COLONIAL BANCGROUP INC
CNB
| $0 | ﹤0.01% |
+29,586
| New | – |
|
Similar funds
AT
BPCA
HIG
H
LFDLE
PRIG
PO
GC
Charles D. Hyman's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Charles D. Hyman, which disclosed 145 positions worth $486M. Its ten largest holdings account for 30% of the portfolio.
Its largest position is Berkshire Hathaway Class B: 201,129 shares worth $22.5M.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, followed by Consumer Staples and Healthcare.
- Charles D. Hyman's largest Q2 2013 buy was Berkshire Hathaway Class B: 201,129 shares worth $22.5M.
- Charles D. Hyman's ten largest holdings make up 30% of its $486M portfolio in Q2 2013.
- Charles D. Hyman disclosed 145 positions in Q2 2013, its first 13F filing on record.
Based on Charles D. Hyman's 13F filing for Q2 2013, filed 24 Jul 2013.